The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review

Documenti analoghi

• Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
  di: Abel Tesfai, et al.
  Pubblicazione: (2024)
• Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
  di: Esther H. J. Hamoen, et al.
  Pubblicazione: (2025)
• Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
  di: Stijn M. van den Bosch, et al.
  Pubblicazione: (2026)
• Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
  di: Yuki Teramoto, et al.
  Pubblicazione: (2026)
• Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
  di: Joshua Yi Min Tung, et al.
  Pubblicazione: (2026)